Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G, Kostov B, Brito-Zerón P, Vissink A, Mandl T, Hinrichs AC, Quartuccio L, Baldini C, Seror R, Szántó A, Isenberg D, Gerli R, Nordmark G, Rasmussen A, Solans-Laque R, Hofauer B, Sène D, Pasoto SG, Rischmueller M, Praprotnik S, Gheita TA, Danda D, Armağan B, Suzuki Y, Valim V, Devauchelle-Pensec V, Retamozo S, Kvarnstrom M, Sebastian A, Atzeni F, Giacomelli R, Carsons SE, Kwok SK, Nakamura H, Fernandes Moça Trevisani V, Flores-Chávez A, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.
Hernández-Molina G, et al. Among authors: szanto a.
Rheumatology (Oxford). 2022 Dec 23;62(1):243-255. doi: 10.1093/rheumatology/keac205.
Rheumatology (Oxford). 2022.
PMID: 35385104